Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Lannett Company, Inc.    LCI

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops, manufactures and distributes generic prescription pharmaceutical products

Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products.

Its pharmaceutical products are distributed to drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations.

It also provides laboratory services which involves analytical, development, stability, and product identification; product formulation; granulation blending; encapsulation; compression; coating; and packaging. The company was founded in 1942 and is headquartered in Philadelphia, PA.
Managers
NameAgeSinceTitle
Arthur P. Bedrosian702000Chief Executive Officer & Director
Jeffrey Farber562003Chairman
Martin P. Galvan, CPA642011CFO, Treasurer & Vice President-Finance
Robert Ehlinger592006Chief Information Officer & VP-logistics
David A. Drabik482010Lead Independent Director
Paul Taveira562012Independent Director
James M. Maher632013Independent Director
Albert R. Paonessa III562015Independent Director
Kevin R. Smith562002Senior Vice President-Sales & Marketing
Mahendra Dedhiya PhD, MBA672015Vice President-Scientific Affairs
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 37,438,340 27,512,581 73.5% 545,963 1.5% 73.5%
Shareholders
NameEquities%
Telemus Capital LLC 5,854,310 15.9%
Jeffrey Farber 4,638,874 12.6%
David Farber 3,789,904 10.3%
BlackRock Fund Advisors 2,736,183 7.42%
The Vanguard Group, Inc. 2,059,084 5.58%
Invesco PowerShares Capital Management LLC 2,019,632 5.47%
Coatue Management LLC 1,805,431 4.89%
SSgA Funds Management, Inc. 1,144,621 3.10%
Thompson, Siegel & Walmsley LLC 901,490 2.44%
Deerfield Management Company LP 895,591 2.43%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
LANNETT COMPANY, INC.1 103
JOHNSON & JOHNSON14.66%325 050
ROCHE HOLDING LTD.-11.18%218 395
NOVARTIS AG-8.70%214 744
PFIZER INC.4.21%207 809
MERCK & CO., INC.17.66%174 098
GLAXOSMITHKLINE PLC20.39%104 476
SANOFI-14.01%99 053
ALLERGAN PLC-23.62%96 589
BRISTOL-MYERS SQUIBB C..-19.35%94 370
NOVO NORDISK A/S-25.78%90 059
ELI LILLY AND CO-5.63%89 588
ASTRAZENECA PLC11.99%85 496
BAYER AG-21.00%84 924
ABBOTT LABORATORIES-7.19%62 019
SHIRE PLC8.98%61 413
TAKEDA PHARMACEUTICAL ..-19.32%37 568
ASTELLAS PHARMA INC-7.48%33 972
MYLAN NV-23.84%22 498
CHUGAI PHARMACEUTICAL ..-12.35%20 208
EISAI CO., LTD-18.84%19 025
Sector Pharmaceuticals - NEC
Lannett Company, Inc. : Connections
Cranbrook & Co. Llc
Generic Pharmaceutical Co.
Auburn Pharmaceuticals, Inc.
Grason-Stadler, Inc.
National Response Corp.
The American Institute of Certified Public Accountants
Healthcare Distribution Management Association
Company contact information
Lannett Co., Inc.
13200 Townsend Road
Philadelphia, PA 19154

Phone : +1.215.333.9000
Fax : +1.215.333.9004
Web : www.lannett.com
© 2016 People , Fundamentals and Ownership